Denis Chem Lab Limited

DENISCHEM6

INE051G01012

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:58 28/06/2024 BST			5-day change	1st Jan Change
190 ^INR	-1.43%		-6.75%	+49.90%

2021	Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2021	CI
2021	Denis Chem Lab Limited Announces Standalone Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2021	CI

Denis Chem Lab Limited Recommends Final Dividend for the Financial Year 2023-24 Ended on 31St March, 2024

May 28, 2024 at 09:54 am

Denis Chem Lab Limited Recommended a Final dividend of INR 2.50 per Equity Share of INR 10/- each for the financial year 2023-24 ended on 31st March, 2024, subject to approval of shareholders at the ensuing Annual General Meeting.

Latest news about Denis Chem Lab Limited

Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2021	13/08/21	CI
Denis Chem Lab Limited Announces Standalone Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2021	07/06/21	CI
Denis Chem Lab Limited Announces Standalone Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2020	26/06/20	CI
Denis Chem Lab Limited Announces Resignation of Nahoosh J. Jariwala as Independent Director	24/02/20	CI
Denis Chem Lab Limited Reports Unaudited Earnings Results for the Quarter and Nine Months Ended on 31 December, 2019	13/02/20	CI
Denis Chem Lab Limited Announces Resignation of Janak G. Nanavati as Independent Director	14/12/19	CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2019	13/08/19	CI
Denis Chem Lab Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2019	25/05/19	CI
Denis Chem Lab Limited Appoints Nahoosh Jayvadan Jariwala as an Independent Director	18/03/19	CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018	11/02/19	CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	05/11/18	CI
Denis Chem Lab Limited Announces Audited Earnings Results for the Year Ended March 31, 2018	17/08/18	CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the Quarter Ended June 30, 2018	14/08/18	CI
Denis Chem Lab Limited Announces Board Changes	20/07/18	CI
Denis Chem Lab Limited Reports Audited Standalone Earnings Results for Fourth Quarter and Full Year Ended March 31, 2018	24/05/18	CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017	14/02/18	CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2017	14/12/17	CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the Quarter Ended June 30, 2017	14/09/17	CI
Denis Chem Lab Limited Announces Audited Earnings Results for the Year Ended March 31, 2017	19/08/17	CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2017	26/05/17	CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016	09/02/17	CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2016	10/11/16	CI
Denis Chem Lab Limited Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2016	12/08/16	CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2016	24/05/16	CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015	30/01/16	CI

Chart Denis Chem Lab Limited

Duration

Period

More charts

Company Profile

Denis Chem Lab Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing pharmaceutical transfusion solution in bottles. It offers a range of sterile intravenous injectables for human and veterinary consumption. Its product offerings include carbohydrate solutions, carbohydrate in sodium chloride solutions, sodium chloride solutions, potassium chloride solutions, sodium lactate/ Ringer's solution, multi electrolyte solutions, dialysis solutions, mannitol solutions, irrigation solutions, plasma volume expanders, amino acids, antibiotic solutions and other miscellaneous products. It manufactures sterile intravenous injectables in filled volumes ranging from 100 milliliters to 10 liters. In addition to manufacturing its own products, it sells under its own brands. The Company also uses its facility to manufacture products on a contract basis for third parties, including certain multinational pharmaceutical companies.

Sector

Pharmaceuticals

Calendar

12/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DENIS CHEM LAB LIMITED	+49.90%	31.63M
ELI LILLY AND COMPANY	+55.32%	815B
NOVO NORDISK A/S	+44.05%	641B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+16.57%	242B
ROCHE HOLDING AG	+2.04%	224B
NOVARTIS AG	+13.31%	218B
AMGEN INC.	+8.48%	168B

Other Pharmaceuticals